Raloxifene

In the US, Raloxifene (raloxifene systemic) is a member of the following drug classes: hormones/antineoplastics, selective estrogen receptor modulators and is used to treat Breast Cancer - Prevention, Osteoporosis and Prevention of Osteoporosis.

US matches:

• Raloxifene


• Raloxifene Hydrochloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

G03XC01

CAS registry number (Chemical Abstracts Service)

0084449-90-1

Chemical Formula

C28-H27-N-O4-S

Molecular Weight

473

Therapeutic Category

Selective estrogen receptor modulator (SERM)

Chemical Name

Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]-

Foreign Names

• Raloxifenum (Latin)
• Raloxifen (German)
• Raloxifène (French)
• Raloxifeno (Spanish)

Generic Names

• Raloxifene (OS: BAN)
• Raloxifène (OS: DCF)
• Keoxifene (IS)
• LY 139481 (IS: Lilly)
• Raloxifene Hydrochloride (OS: BANM, USAN)
• Keoxifene Hydrochloride (IS)
• LY 156758 (IS: Lilly)
• Raloxifene Hydrochloride (PH: USP 32)

Brand Names

• Evista
  Eli Lilly, Tunisia



• Raxeto
  Dosa, Argentina



• Aloxif
  Incepta, Bangladesh



• Apo-Raloxifene
  Apotex, Canada



• Bonmax
  Zydus Cadila, India; Zydus Cadila, Myanmar



• Celvista
  Eli Lilly NL B.V., Luxembourg; Lilly, Thailand



• Evista
  Daiichi Sankyo, Switzerland; Daiichi Sankyo, Germany; Daiichi Sankyo, France; Daiichi Sankyo, Italy; Daiichi Sankyo, Norway; Eli Lilly, Bulgaria; Eli Lilly, Canada; Eli Lilly, United Kingdom; Eli Lilly, Indonesia; Eli Lilly, Japan; Eli Lilly, Netherlands; Eli Lilly, Oman; Eli Lilly, South Africa; Eli Lilly NL B.V., Luxembourg; Lilly, Argentina; Lilly, Austria; Lilly, Australia; Lilly, Belgium; Lilly, Bahrain; Lilly, Chile; Lilly, Colombia; Lilly, Costa Rica; Lilly, Czech Republic; Lilly, Denmark; Lilly, Dominican Republic; Lilly, Spain; Lilly, Greece; Lilly, Guatemala; Lilly, Hong Kong; Lilly, Honduras; Lilly, Hungary; Lilly, Ireland; Lilly, Israel; Lilly, Iceland; Lilly, Sri Lanka; Lilly, Mexico; Lilly, Malaysia; Lilly, Nicaragua; Lilly, New Zealand; Lilly, Panama; Lilly, Peru; Lilly, Philippines; Lilly, Portugal; Lilly, Romania; Lilly, Serbia; Lilly, Singapore; Lilly, Slovenia; Lilly, El Salvador; Lilly, Turkey; Lilly, Taiwan; Lilly, United States; Lyfjaver, Iceland; Meda, Finland; Meda, Sweden; Medis Adria, Croatia (Hrvatska); Sankyo, Slovakia



• Ketidin
  Montpellier, Argentina



• Optruma
  Daiichi Sankyo, Germany; Eli Lilly NL B.V., Luxembourg; Laboratorios Dr Esteve, Spain; Menarini, Italy; Pierre Fabre Médicament, France; Vitoria, Portugal



• Oxilar
  Square, Bangladesh



• Ralox
  Orion, Bangladesh

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.